NATURE’S SUNSHINE PRODUCTS, INC. Trading Securities, Realized Loss
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Trading Securities, Realized Loss of $37.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement › Other Income
us-gaap:TradingSecuritiesRealizedLoss · last filed 2016-11-09
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for the quarter ending 2013-06-30 was $12.00K, a 53.85% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for the quarter ending 2012-06-30 was $26.00K, a 333.33% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for the quarter ending 2011-12-31 was -$41.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for the quarter ending 2011-09-30 was $121.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for fiscal 2012 was $8.00K, a 60.00% increase from fiscal 2011.
- NATURE’S SUNSHINE PRODUCTS, INC. trading securities, realized loss for fiscal 2011 was $5.00K.
| Period end | Trading Securities, Realized Loss 3 month | Trading Securities, Realized Loss 6 month | Trading Securities, Realized Loss 9 month | Trading Securities, Realized Loss 12 month |
|---|---|---|---|---|
| 2015-09-30 | $37.00K 10-Q · filed 2016-11-09 | |||
| 2013-06-30 | $12.00K 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | $8.00K 10-K · filed 2013-03-07 | |||
| 2012-06-30 | $26.00K 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $80.00K derived: sum of 2 quarters · filed 2013-03-07 | $86.00K derived: sum of 3 quarters · filed 2013-03-07 | $5.00K 10-K · filed 2013-03-07 |
| 2011-09-30 | $121.00K 10-Q · filed 2012-11-06 | $127.00K derived: sum of 2 quarters · filed 2012-11-06 | $46.00K 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $6.00K 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |